Primary experimental recordPositive observation

PMC10043419::ACT000069

MPI-SP

Evidence text

Paper-level observation

Both of them had a pronounced reduction of their viabilities when treated with bioengineered OMVs (OMV^MPI-N, OMV^MPI-SP, and OMV^MPI-C) for 24 h when compared with OMV^WT treatment.

figureConfidence: medium

Assay observation

Activity

Anticancer

Subtype

Cytotoxic

Measure

cell_viability

Comparator

Raw observation

reduced viability

Normalized measurement

=24

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

MB49

Assay method

Not reported by source

Sequence

Not reported by source

Standardization

insufficient information

Source publication

Bioengineered bacterial outer membrane vesicles encapsulated Polybia–mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy

Frontiers in Immunology · 2023

DOI 10.3389/fimmu.2023.1129771 PMC10043419

Parent mention

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.